Martha Morrell

Insider Reports History

Entity
Individual
Location
C/O Neuropace Inc, 455 N. Bernardo Avenue, Moutain View, CA
Signature
/s/ Rebecca Kuhn, Attorney-In-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Martha Morrell:

Stock Role Class Num Shares Value Price $ Report Date Ownership
NeuroPace Inc Chief Medical Officer Common Stock 90.3K $1.37M $15.17 Feb 27, 2024 Direct
NeuroPace Inc Chief Medical Officer Stock Option (Right to Buy) 25K Feb 27, 2024 Direct

Insider Reports Filed by Martha Morrell

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NPCE NeuroPace Inc Feb 27, 2024 2 $0 4 Feb 28, 2024 Chief Medical Officer
NPCE NeuroPace Inc Feb 2, 2024 2 -$265K 4 Feb 6, 2024 Chief Medical Officer
NPCE NeuroPace Inc Jan 30, 2024 3 -$209K 4 Feb 1, 2024 Chief Medical Officer
NPCE NeuroPace Inc Jan 24, 2024 2 -$12.4K 4 Jan 26, 2024 Chief Medical Officer
NPCE NeuroPace Inc Dec 26, 2023 2 -$136K 4 Dec 28, 2023 Chief Medical Officer
NPCE NeuroPace Inc Dec 20, 2023 1 -$27.7K 4 Dec 22, 2023 Chief Medical Officer
NPCE NeuroPace Inc Dec 6, 2023 1 -$89.8K 4 Dec 7, 2023 Chief Medical Officer
NPCE NeuroPace Inc Feb 20, 2023 1 $0 4 Feb 22, 2023 Chief Medical Officer
NPCE NeuroPace Inc Oct 7, 2022 4 $15.00 4 Oct 11, 2022 Chief Medical Officer
NPCE NeuroPace Inc Mar 3, 2022 2 $0 4 Mar 7, 2022 Chief Medical Officer
NPCE NeuroPace Inc Jun 4, 2021 2 $0 4/A Jun 29, 2021 Chief Medical officer